NVNO logo

enVVeno Medical Corporation (NVNO)

Profile

Full Name

enVVeno Medical Corporation

Ticker

NASDAQ: NVNO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 31, 2018

Indexes

Not included

Website

https://www.envveno.com

Employees

37

Key Details

Price

$0.97(-17.09%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.27(+33.51% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.97
    NVNO price is $0.97

    30-Day Relative Volume

    7.92
    NVNO 30-day relative volume is 7.92

    Price Performance

    Price Today change

    -17.09%
    NVNO price is down -17.09% today

    Price YTD change

    -67.88%
    NVNO price is down -67.88% since January 1st

    Price 1-year change

    -81.7%
    NVNO price is down -81.7% year-on-year

    Price 3-year change

    -84.55%
    NVNO price is down -84.55% over the past 3 years

    Price Range

    Price All-time high

    $141.00
    NVNO price is currently -99.31% below its historical high of $141.00

    Price 3-year low

    $0.90
    NVNO price is currently +7.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $18.67M
    NVNO market capitalization is $18.67 million

    Market cap 3-year change

    -68.61%
    NVNO market capitalization is down -68.61% over the past 3 years

    Market cap All-time high

    $101.05M
    NVNO market capitalization is currently -81.52% below its historical high of $101.05 million

    Market cap sector rank

    22.55%
    NVNO market capitalization is higher than 22.55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +44.39%
    NVNO shares outstanding is up +44.39% year-on-year

    Shares Outstanding 3-Year Change

    +103.25%
    NVNO shares outstanding is up +103.25% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.39
    NVNO beta is 1.39

    200-day SMA

    $3.46
    NVNO price is currently -71.99% below its 200-day simple moving average

    50-day SMA

    $4.36
    NVNO price is currently -77.76% below its 50-day simple moving average

    RSI

    18.00
    NVNO 14-day relative strength index is 18.00

    Volume

    7.92
    NVNO 30-day relative volume is 7.92

    ATR

    $0.59
    NVNO average true range is $0.59

    10-day Historical Volatility

    368.81%
    NVNO 10-day historical volatility is 368.81%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NVNO annual revenue is $0.00

    Revenue Analysts estimate

    -
    NVNO annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    NVNO annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.61%
    NVNO annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    -$1.27
    NVNO annual earnings per share is -$1.27

    EPS Analysts estimate

    -$1.08
    NVNO annual earnings per share is currently +17.59% higher than the consensus analysts' forecast

    EPS 1-year change

    +33.51%
    NVNO annual earnings per share is up +33.51% year-on-year

    EPS Sector rank

    46.64%
    NVNO annual earnings per share is higher than 46.64% of companies in Healthcare sector

    Profit

    Gross profit

    -$528.00K
    NVNO annual gross profit is -$528.00 thousand

    Gross margin

    -
    NVNO annual gross profit margin value is unknown

    Operating profit

    -$23.83M
    NVNO annual operating income is -$23.83 million

    Operating margin

    -
    NVNO annual operating profit margin value is unknown

    Net income

    -$21.82M
    NVNO annual net profit is -$21.82 million

    Net margin

    -
    NVNO annual net profit margin value is unknown

    Expenses

    Total expenses

    $21.82M
    NVNO annual total expenses is $21.82 million

    Operating expenses

    $23.30M
    NVNO annual total operating expenses is $23.30 million

    Cost of goods sold

    $528.00K
    NVNO annual cost of goods sold is $528.00 thousand

    Selling, general & administrative expenses

    $0.00
    NVNO annual SGA is $0.00

    Depreciation and amortization

    $528.00K
    NVNO annual depreciation & amortization is $528.00 thousand

    Interest expense

    $0.00
    NVNO annual interest expense is $0.00

    Income tax

    $0.00
    NVNO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$23.83M
    NVNO annual earnings before interest & taxes is -$23.83 million

    EBITDA

    -$23.30M
    NVNO annual EBITDA is -$23.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $44.95M
    NVNO annual total assets is $44.95 million

    Non current assets

    $1.22M
    NVNO annual long term assets is $1.22 million

    Current assets

    $43.73M
    NVNO annual total current assets is $43.73 million

    Cash and cash equivalents

    $43.15M
    NVNO annual cash & cash equivalents is $43.15 million

    Accounts receivable

    -
    NVNO annual accounts receivable value is unknown

    Inventory

    $0.00
    NVNO annual inventory is $0.00

    Liabilities

    Total liabilities

    $2.79M
    NVNO annual total liabilities is $2.79 million

    Long term liabilities

    $700.00K
    NVNO annual total long term liabilities is $700.00 thousand

    Current liabilities

    $2.10M
    NVNO annual total current liabilities is $2.10 million

    Accounts payable

    $1.01M
    NVNO annual accounts payable is $1.01 million

    Debt

    Total debt

    $1.06M
    NVNO annual total debt is $1.06 million

    Total debt 1-year change

    -24.11%
    NVNO annual total debt is down -24.11% year-on-year

    Long term debt

    $700.00K
    NVNO annual long term debt is $700.00 thousand

    Short term debt

    $364.00K
    NVNO annual short term debt is $364.00 thousand

    Equity & Capital

    Shareholders equity

    $42.16M
    NVNO annual stockholders equity is $42.16 million

    Book value

    $42.16M
    NVNO annual book value is $42.16 million

    Retained earnings

    -$151.85M
    NVNO annual retained earnings is -$151.85 million

    Working capital

    $41.64M
    NVNO annual working capital is $41.64 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$16.84M
    NVNO annual cash flow from operations is -$16.84 million

    Cash from operations 1-year change

    +10.71%
    NVNO annual cash flow from operations is up +10.71% year-on-year

    Cash from investing

    $1.33M
    NVNO annual cash flow from investing activities is $1.33 million

    Cash from investing 1-year change

    +116.97%
    NVNO annual cash flow from investing activities is up +116.97% year-on-year

    Cash from financing

    $13.64M
    NVNO annual cash flow from financing activities is $13.64 million

    Cash from financing 1-year change

    -47.12%
    NVNO annual cash flow from financing activities is down -47.12% year-on-year

    CAPEX

    CAPEX

    $37.00K
    NVNO annual capital expenditures is $37.00 thousand

    CAPEX 1-year change

    +12.12%
    NVNO annual capital expenditures is up +12.12% year-on-year

    Free Cash Flow

    Free cash flow

    -$16.88M
    NVNO annual free cash flow is -$16.88 million

    Free cash flow 1-year change

    +10.67%
    NVNO annual free cash flow is up +10.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    NVNO annual gross profit margin value is unknown

    Operating margin

    -
    NVNO annual operating profit margin value is unknown

    Net margin

    -
    NVNO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -46.63%
    NVNO annual return on assets is -46.63%

    ROE

    -49.39%
    NVNO annual return on equity is -49.39%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NVNO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NVNO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.56
    NVNO price to book ratio is 0.56

    PB ratio Sector rank

    26.64%
    NVNO price to book ratio is higher than 26.64% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    NVNO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    NVNO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$15.59M
    NVNO enterprise value is -$15.59 million

    Enterprise value Sector rank

    5.1%
    NVNO enterprise value is higher than 5.1% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.64
    NVNO EV/EBITDA is 0.64

    EV/EBITDA Sector rank

    72.11%
    NVNO EV/EBITDA is higher than 72.11% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    20.88
    NVNO annual current ratio is 20.88

    Quick ratio

    20.88
    NVNO annual quick ratio is 20.88

    Leverage

    Debt to equity

    0.03
    NVNO annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    NVNO annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NVNO piotroski f-score value is unknown

    Altman Z-Score

    -1.36
    NVNO altman z-score is -1.36

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with NVNO included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for enVVeno Medical Corporation?
    • Does enVVeno Medical Corporation pay dividends?
    • What sector is enVVeno Medical Corporation in?
    • What industry is enVVeno Medical Corporation in?
    • What country is enVVeno Medical Corporation based in?
    • When did enVVeno Medical Corporation go public?
    • Is enVVeno Medical Corporation in the S&P 500?
    • Is enVVeno Medical Corporation in the NASDAQ 100?
    • Is enVVeno Medical Corporation in the Dow Jones?
    • When was enVVeno Medical Corporation's last earnings report?
    • When does enVVeno Medical Corporation report earnings?

    What is the ticker symbol for enVVeno Medical Corporation?

    The ticker symbol for enVVeno Medical Corporation is NASDAQ:NVNO

    Does enVVeno Medical Corporation pay dividends?

    No, enVVeno Medical Corporation does not pay dividends

    What sector is enVVeno Medical Corporation in?

    enVVeno Medical Corporation is in the Healthcare sector

    What industry is enVVeno Medical Corporation in?

    enVVeno Medical Corporation is in the Medical Devices industry

    What country is enVVeno Medical Corporation based in?

    enVVeno Medical Corporation is headquartered in United States

    When did enVVeno Medical Corporation go public?

    enVVeno Medical Corporation's initial public offering (IPO) was on May 31, 2018

    Is enVVeno Medical Corporation in the S&P 500?

    No, enVVeno Medical Corporation is not included in the S&P 500 index

    Is enVVeno Medical Corporation in the NASDAQ 100?

    No, enVVeno Medical Corporation is not included in the NASDAQ 100 index

    Is enVVeno Medical Corporation in the Dow Jones?

    No, enVVeno Medical Corporation is not included in the Dow Jones index

    When was enVVeno Medical Corporation's last earnings report?

    enVVeno Medical Corporation's most recent earnings report was on August 7, 2025

    When does enVVeno Medical Corporation report earnings?

    The date for enVVeno Medical Corporation's next earnings report has not been announced yet
    On this page